Forget Biotech, Follow the Pharma Dividends

Related Link: 

Biotech stocks have long outperformed their big pharmaceutical counterparts. But that could change if the recent selloff persists.

BNY Mellon ETF Bug Could Still Sting

Related Link: 

Bank of New York Mellon’s computer glitch may prove costly.

Netflix Ends Epix Cable Deal, Pulling High-Profile Films

Related Link: 

Streaming service to focus on originals and exclusives; Hulu lands a film trove

Rocky Markets Could Be Good for These Stocks

Related Link: 

Exchanges and market makers are getting a fresh look from portfolio managers seeking out investments likely to benefit from the large market swings.

Insurers Could Use More Calamity

Related Link: 

On the 10th anniversary of Hurricane Katrina, insurers are suffering from years of calm seas and low rates.

China's Next Problem: Paying for Its Stock-Market Bailout

Related Link: 

China will need to pay the cost of cleaning up its stock-market bailout.

U.S. Port Traffic Hinted at China Slowdown

Related Link: 

Long before investors lost faith in the Chinese stock market, something seemed amiss at the ports of Long Beach and Los Angeles. The number of containers coming from China was up, but beginning in 2013, fewer loads were being sent in the other direction.

Campbell's Quest for Souped-Up Sales

Related Link: 

In the past year, Campbell Soup started making organic varieties of classic products, cut its use of artificial ingredients, and pledged to remove high-fructose corn syrup from more foods. On Thursday, it will shed light on whether those efforts are souping up lackluster sales.

Stock Market Investors Should Watch the Credit Canary

Related Link: 

The corporate bond market could give vital clues to equities investors about the outlook for growth and inflation.

Fed's Fischer: 'Good Reason' to Think U.S. Inflation Will Move Higher

Related Link: 

The Fed‘s Stanley Fischer said there is “good reason” to think sluggish U.S. inflation will firm and move back toward the U.S. central bank’s 2% annual target, touching on a significant assessment facing the Fed ahead of its September policy meeting.

Syndicate content